Alana Hippensteele, Lead Editor

Following a review of the latest interim data released by AstraZeneca on its US phase 3 clinical trial assessing the 2-dose AZD1222 COVID-19 vaccine, the Data and Safety Monitoring Board (DSMB) expressed concern at the inclusion of what may have been outdated data.

Phase 3 clinical testing of a plant-derived COVID-19 vaccine candidate in combination with a pandemic adjuvant commenced following approval to proceed with participant enrollment from regulatory authorities in both Canada and the United States.

The first participants were dosed in the phase 2/3 KidCOVE study investigating vaccine candidate mRNA-1273 against COVID-19 in children aged 6 months to less than 12 years of age.

In the 4th century BCE, Hippocrates, the founding father of medicine, established that the best cure for hemorrhoids was through the application of the curative properties of fire.

Results of clinical trials have shown that a nitric oxide nasal spray is both a safe and effective antiviral treatment to prevent COVID-19 transmission and symptom duration, as well as reduce symptom severity and damage in those already infected.

The FDA has granted priority review for an NDA for the hypoxia-inducible factor-2 alpha inhibitor MK-6482 for the potential treatment of patients with von Hippel-Lindau disease-associated renal cell carcinoma that does not require immediate surgery.

Although clostridioides difficile is the leading cause of health care-associated infection in the United States, there are currently only 2 antibiotics available for its treatment: vancomycin and fidaxomicin.

The Medicare payment amount for administering the COVID-19 vaccine is increasing, according to a statement from the Centers for Medicare and Medicaid Services.

The FDA announced that it will hold a public meeting of the Oncologic Drugs Advisory Committee from April 27 to 29 to address the indications granted accelerated approval for 6 therapies.

For millennia, humans have linked feces and disease, making the connection that since it’s gross, it’s probably also harmful.

An ongoing phase 2 clinical study has begun to vaccinate patients with a modified version of Moderna’s COVID-19 vaccine.

A recent survey showed that there is a significant preference among Americans to receive COVID-19 vaccines from a trusted health care provider, such as a pharmacist or physician.

New, long-term data from open-label extensions of a pair of phase 3 studies of bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets showed the sustained efficacy and safety profile of the treatment.

Research on a novel, investigational combined oral contraceptive containing drospirenone and estetrol showed that the treatment resulted in limited changes in endocrine markers.

In a recent statement, Walgreens announced that it has administered approximately 5 million COVID-19 vaccinations at long-term care facilities, in its stores, and through its vaccination clinics.

The HIV epidemic continues while populations are less likely to reach out for testing, prevention, and treatment during the pandemic due to a variety of challenges.

The FDA has issued an emergency use authorization (EUA) for a COVID-19 diagnostic test that can confirm recent or prior COVID-19 infection.

Due to new medications in discovery, the outcomes for patients with cancer are increasingly improving; however, the cost of this improved care is also increasing.

Research over the past decade has shown that PV can be associated with a reduction in survival compared with age- and gender-matched population controls.

Research over the past decade has shown that PV can be associated with a reduction in survival compared with age- and gender-matched population controls.

In Vienna in the 1770s, a young physician named Franz Friedrich Anton Mesmer happened to meet a Jesuit priest named Maximilian Hell who was conducting medical experiments on patients with rheumatism.

One way of approaching the process of allowing patients to self-report their symptoms is through an electronic patient-reported outcomes (ePRO) system.

Throughout the COVID-19 pandemic, patients hospitalized with the disease have had more to face than just the fight against COVID-19, as co-infection with drug-resistant pathogens has been shown to also contribute to rates of mortality and readmission.

A recent study found that a combination of robust vaccination programs and strict physical distancing rules may be effective in the prevention of future COVID-19 infection surges.

APhA commended President Biden’s signing of the executive order in a press release, noting that adequate drug supply would be critical to ensuring pharmacists’ ability to provide care to patients during the COVID-19 pandemic.

It has taken both time and effort to address the equitable allocation of COVID-19 vaccinations, and in communities such as Prince George’s County in Maryland, significant effort has been made to address barriers to access.

While working as a stage manager in a theater in Bombay, India, Dinshah Ghadiali began to read about the potential of color therapy to cure disease.

A global phase 2/3 study of opaganib in patients with severe COVID-19 is set to be expanded, following FDA review of the data from the phase 2 study of the drug and RedHill Biopharma’s receipt of its recommendations.

A more sensitive test capable of detecting heart function issues early in cancer treatment may be beneficial in preventing heart failure.

The time to treatment deterioration in pain in chest, dyspnea, and cough was found to be comparable between patients who received lorlatinib and patients who received crizotinib.